Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
Stefano Rusconi(University of Milan), GC Marchetti(University of Milan), S Fariña(Università Cattolica del Sacro Cuore), Gabriella d’Ettorre(Policlinico Umberto I), Fulvio Adorni(Institute of Biomedical Technologies), Luca Butini(Vita-Salute San Raffaele University), Michelle Capasso(University of Milan), AR Buonomini(University of Rome Tor Vergata), A Capetti(Luigi Sacco Hospital), Alessandro Soria(University of Milano-Bicocca), Andrea Di Pietro(The University of Melbourne), Emanuele Focà(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Giancarlo Orofino(Ospedale Amedeo di Savoia), Chiara Tommasi(University of Parma), P Vitiello(University of Milan), C Abeli(Ospedale di Circolo di Busto Arsizio), Marco D’Annunzio, Elisa Colella, Esther Merlini(Ospedale San Paolo), Stefano Bonora(Ospedale Amedeo di Savoia), MP Trotta(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Paola Meraviglia(Luigi Sacco Hospital), Daniela Francisci(University of Perugia), Antonio Di Biagio
Cited by 10
Related Papers
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019
|Annals of Neurology|2020|299
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272